Valirx (VAL)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

9.75p
   
  • Change Today:
      0.85p
  • 52 Week High: 34.25
  • 52 Week Low: 8.78
  • Currency: UK Pounds
  • Shares Issued: 102.32m
  • Volume: 876,620
  • Market Cap: £9.98m
  • RiskGrade: 435

Regulatory News

Incorporation of Inaphaea BioLabs Limited 01-Mar-2023 07:00 RNS
Second Price Monitoring Extn 24-Feb-2023 16:40 RNS
Price Monitoring Extension 24-Feb-2023 16:35 RNS
Result of GM, Issue of Equity 02-Feb-2023 12:45 RNS
Operational Update 31-Jan-2023 07:02 RNS
Holding(s) in Company 31-Jan-2023 07:00 RNS
Broker Offer Results 17-Jan-2023 16:36 RNS
Posting of Circular and Notice of General Meeting 17-Jan-2023 09:22 RNS
Launch of Broker Offer 13-Jan-2023 07:01 RNS
Issue of Equity & Proposed Broker Offer 13-Jan-2023 07:00 RNS
Holding(s) in Company 14-Dec-2022 17:01 RNS
Holding(s) in Company 07-Dec-2022 13:06 RNS
Second Price Monitoring Extn 06-Dec-2022 16:40 RNS
Price Monitoring Extension 06-Dec-2022 16:35 RNS
Quarterly Operational and Strategy Update 06-Dec-2022 07:00 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Valirx Market Data

Currency UK Pounds
Share Price 9.75p
Change Today 0.85p
% Change 9.55 %
52 Week High 34.25
52 Week Low 8.78
Volume 876,620
Shares Issued 102.32m
Market Cap £9.98m
RiskGrade 435

Valirx Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
38.77% below the market average38.77% below the market average38.77% below the market average38.77% below the market average38.77% below the market average
26.67% below the sector average26.67% below the sector average26.67% below the sector average26.67% below the sector average26.67% below the sector average
Price Trend
86.4% below the market average86.4% below the market average86.4% below the market average86.4% below the market average86.4% below the market average
55.56% below the sector average55.56% below the sector average55.56% below the sector average55.56% below the sector average55.56% below the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 0
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 1
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Valirx Dividends

No dividends found

Trades for 24-Mar-2023

Time Volume / Share Price
16:28 28,390 @ 9.66p
16:28 21,934 @ 9.66p
16:27 18,000 @ 9.90p
16:23 100,000 @ 10.00p
16:21 5,382 @ 9.80p

Valirx Key Personnel

CFO Gerald Desler
CEO Suzanne Dilly

Top of Page